Bromazepam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401501This classification denotes a benzodiazepine with the molecular formula C14H10BrN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X015L14V0O, chemically known as 1,3-dihydro-7-bromo-5-(2-pyridyl)-2h-1,4-benzodiazepin-2-one but generally known as bromazepam, which bears US NIH Compound Identifier 2441. European Medicines Agency schedules Bromazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05907MIG. The term BROMAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules bromazepam in its Anatomical Therapeutic Chemical (ATC) Classification. BROMAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bromazepam under HS 29333300 and SITC 51574. As of Q4 2014, BROMAZEPAM remains the US FDA Preferred Term for this commodity. Bromazepam bears US NLM identifiers UMLS ID C0006213 and NCI Concept Code C87454. SMILES: BRC1CC2C(NC(=O)CN=C2C2NCCCC2)CC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.